Clinical trials sponsored by Astellas Pharma Global Development, Inc.
9
Recruiting trials
15
Conditions studied
Phase breakdown
Phase 1 6Phase 2 2Phase 3 2
Conditions studied
Recruiting trials led by Astellas Pharma Global Development, Inc.
- A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
- A Study of ASP1002 in Adults for Treatment of Solid Tumors
- A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer
- A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
- A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer
- Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Common questions
How many trials is Astellas Pharma Global Development, Inc. recruiting for?
Astellas Pharma Global Development, Inc. is the lead sponsor of 9 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.